Overview


Animal-derived immune globulin products are pharmaceutical preparations made from the blood plasma of animals, typically horses or other mammals, that have been immunized against specific diseases or antigens. These products are used for passive immunization, where the immune globulins (Ig) (also known as antibodies) present in the product provide temporary protection against a particular disease or toxin. Currently, immune globulins are the most commonly used blood product. It is obtained by processing plasma; methods to reduce plasma viral loads have evolved, including pasteurization, nanofiltration, solvent/ detergent treatment, and caprylic acid treatment. These methods contribute to improved protection and quality of blood products.

Animal-derived immune globulin products have been historically used to treat or prevent diseases such as rabies, tetanus, botulism, and snakebite envenomation. However, over time, advancements in biotechnology have led to the development of recombinant DNA technology, allowing for the production of human monoclonal antibodies in cell cultures. This has reduced the reliance on animal-derived products and minimized the risk of adverse reactions associated with animal-derived components, such as allergic reactions or transmission of animal-borne infections.

FutureWise Market Research has published a report that provides an insightful analysis animal-derived immune globulin products market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, animal-derived immune globulin products market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Pfizer
  • Rare Disease Therapeutics
  • Instituto Bioclon
  • Merck and Co
  • Sanofi
  • Protherics
  • Genzyme Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Animal-derived Immune Globulin Products Market :

  • In May 2023- Prominent advancements emerged in the field of immunotherapy, particularly concerning the therapeutic agent known as Lymphocyte Immune Globulin, or Anti-thymocyte Globulin (Equine), recognized by its trade name ATGAM. This pioneering product is manufactured by Pharmacia & Upjohn Company LLC, a subsidiary of Pfizer.

The increasing incidence of autoimmune diseases, primary immunodeficiencies, and immune-related disorders has emerged as an effective driver propelling the demand for Animal-derived Immune Globulin Products Market. This surge in demand is fueled by a combination of factors, including an aging global population susceptible to immune-related conditions and the impact of evolving environmental influences. As patients seek effective treatments to manage these complex health challenges, the market for animal-derived immune globulin products experiences steady growth. Moreover, immunology and medical research advancements have profoundly deepened our understanding of immune-related disorders and the pivotal role that immune globulins play in their treatment. This growing knowledge base is a potent driver, fostering the innovation and enhancement of novel immune globulin products tailored for enhanced efficacy, safety, and specificity. Furthermore, the high production and processing costs associated with animal-derived immune globulin products significantly restrain their widespread adoption in the market. These high costs may lead to higher consumer prices and impose a financial burden on healthcare systems. As price sensitivity among patients and healthcare provider increases, there is a heightened risk that the demand for these products may decline, particularly if more affordable and efficient alternatives emerge in the market. Additionally, the availability and supply of suitable animals for sourcing blood plasma, a major component of animal-derived immune globulin products, present a significant constraint due to susceptibility to market fluctuations, outbreak of animal diseases, and logistical complications. These factors may disrupt the fragile supply chain, potentially causing shortages of raw materials and impacting the overall market growth.

By Product Type

  • IVIg Liquid
  • IVIg Powder

By Application

  • Immunodeficiency
  • Autoimmune Disease
  • Acute Infection

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to rapid industrialization and urbanization, they contributed to the growth of the Animal-derived Immune Globulin Products Market. These emerging economies are experiencing a surge in investments directed toward the development of robust infrastructures. The region is witnessing increased infrastructure investment, further creating a substantial demand for Animal-derived Immune Globulin Products and services during the forecast period.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Animal-derived Immune Globulin Products Market By Product Type, By Application and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansion

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Animal-derived Immune Globulin Products Market Variables, Trends and Scope

    •          1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Animal-derived Immune Globulin Products Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Animal-derived Immune Globulin Products Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Animal-derived Immune Globulin Products Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. IVIg Liquid
        2. IVIg Powder

  • 8.   Global Animal-derived Immune Globulin Products Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Immunodeficiency
        2. Autoimmune Disease
        3. Acute Infection

  • 9.   North America Animal-derived Immune Globulin Products Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Animal-derived Immune Globulin Products Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Animal-derived Immune Globulin Products Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Animal-derived Immune Globulin Products Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Pfizer
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Rare Disease Therapeutics
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Instituto Bioclon
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Merck and Co
                   4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sanofi
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Protherics
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Genzyme Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                   administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

Related Market

Hyperimmune Globulins Market

Read More

Immune Globulin Intravenous Market

Read More

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11